The healthcare industry is at a critical juncture, with a multitude of challenges and innovations vying for attention. From the quest for eternal life to the struggles of prescription drug affordability, the landscape is evolving rapidly.
Why It Matters
The issues facing the healthcare industry are complex and multifaceted. Payton Herres, a heart transplant recipient, has spoken out about the "ghost approval" of medication, where patients are approved for coverage but unable to access the medication due to high costs.
"On paper, I have insurance coverage. In real life, I don't have access. That's what I call 'ghost approval,'" Herres writes.
What Experts Say
- 1 in 8 women report drinking during pregnancy, despite the risks of fetal alcohol disorders.
- 9 states are pursuing the idea of prescription drug affordability boards, following Maryland's lead.
- Experts are weighing the risks and benefits of testing a vaccine with unknown protection in the Ebola outbreak.
Key Numbers
- 42% of women report drinking during pregnancy, despite the risks.
- $3.2 billion is the estimated annual cost of fetal alcohol disorders in the United States.
- 12,000 people have died in the Ebola outbreak in the Democratic Republic of Congo.
Key Facts
Background
The quest for eternal life is a topic of increasing interest, with some experts exploring the potential for life extension. The longevity conference brings together founders, investors, biohackers, and others to discuss how to forestall – or even beat – our demise.
What Comes Next
As the healthcare industry continues to evolve, it is likely that we will see increased focus on affordable medication, innovative treatments, and the ethics of life extension. Stay tuned for further developments on these critical issues.
What to Watch
- The impact of Maryland's price cap on Ozempic on the pharmaceutical industry.
- The outcome of the Ebola vaccine testing in the Democratic Republic of Congo.
- The growing interest in life extension and its potential implications for society.